Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotaverine vs Hyoscine-N-butylbromide in ERCP
NCT00731198Phase 3Completed
- Sponsor
- Changhai Hospital
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of drotaverine in bile duct diseases, sponsored by Changhai Hospital. Started Aug 2008; status: completed.
02
Drugs
drotaverine
03
Conditions
bile duct diseases
Beyond the preview
Go deeper on NCT00731198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731198.